<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37300789</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2092-9293</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Genes &amp; genomics</Title><ISOAbbreviation>Genes Genomics</ISOAbbreviation></Journal><ArticleTitle>Whole-genome bisulfite sequencing identified the key role of the Src family tyrosine kinases and related genes in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1187</StartPage><EndPage>1196</EndPage><MedlinePgn>1187-1196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13258-023-01407-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">As a multisystemic autoimmune illness, the basic mechanisms behind the pathophysiology of systemic lupus erythematosus (SLE) remain poorly understood.</AbstractText><AbstractText Label="OBJECTIVE">We aimed to investigate the possible significance of SLE's DNA methylation and gain&#xa0;further&#xa0;insight&#xa0;into potential SLE-related biomarkers and therapeutic targets.</AbstractText><AbstractText Label="METHODS">We used whole genome bisulfite sequencing (WGBS) method to analyze DNA methylation in 4 SLE patients and 4 healthy people.</AbstractText><AbstractText Label="RESULTS">702 differentially methylated regions (DMRs) were identified, and 480 DMR-associated genes were annotated. We found the majority of the DMR-associated elements were enriched in repeat and gene bodies. The top 10 hub genes identified were LCK, FYB, PTK2B, LYN, CTNNB1, MAPK1, GNAQ, PRKCA, ABL1, and CD247. Compared to the control group, LCK and PTK2B had considerably decreased levels of mRNA expression in the SLE group. Receiver operating characteristic (ROC) curve suggested that LCK and PTK2B may be potential candidate biomarkers to predict SLE.</AbstractText><AbstractText Label="CONCLUSIONS">Our study improved comprehension of the DNA methylation patterns of SLE and identified potential biomarkers and therapeutic targets for SLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s) under exclusive licence to The Genetics Society of Korea.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Fang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Suyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Yating</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Dingqi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xvfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Zhimin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kepeng</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinchang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-4540-301X</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China. ossani@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Genes Genomics</MedlineTA><NlmUniqueID>101481027</NlmUniqueID><ISSNLinking>1976-9571</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>OJ9787WBLU</RegistryNumber><NameOfSubstance UI="C042345">hydrogen sulfite</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D019061">src-Family Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019061" MajorTopicYN="Y">src-Family Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37300789</ArticleId><ArticleId IdType="doi">10.1007/s13258-023-01407-4</ArticleId><ArticleId IdType="pii">10.1007/s13258-023-01407-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blasini AM, Brundula V, Paris M, Rivas L, Salazar S, Stekman IL, Rodriguez MA (1998) Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus. J Autoimmun 11:387&#x2013;393</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.1998.0230</ArticleId><ArticleId IdType="pubmed">9802921</ArticleId></ArticleIdList></Reference><Reference><Citation>Bommhardt U, Schraven B, Simeoni L (2019) Beyond TCR signaling: emerging functions of lck in cancer and immunotherapy. Int J Mol Sci 20:3500</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20143500</ArticleId><ArticleId IdType="pubmed">31315298</ArticleId><ArticleId IdType="pmc">6679228</ArticleId></ArticleIdList></Reference><Reference><Citation>Catoni M, Tsang JM, Greco AP, Zabet NR (2018) DMRcaller: a versatile R/Bioconductor package for detection and visualization of differentially methylated regions in CpG and non-CpG contexts. Nucleic Acids Res 46:e114</Citation><ArticleIdList><ArticleId IdType="pubmed">29986099</ArticleId><ArticleId IdType="pmc">6212837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SH, Lv QL, Hu L, Peng MJ, Wang GH, Sun B (2017) DNA methylation alterations in the pathogenesis of lupus. Clin Exp Immunol 187:185&#x2013;192</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12877</ArticleId><ArticleId IdType="pubmed">27690369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(4):S11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId><ArticleId IdType="pmc">4290687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang E, Lee KM, Robbins MD, Duerr JM, Alegre ML, Hambor JE, Neveu MJ, Bluestone JA, Thompson CB (1999) Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J Immunol 162:1270&#x2013;1277</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.162.3.1270</ArticleId><ArticleId IdType="pubmed">9973379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM (2010) The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res 38:1767&#x2013;1771</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp1137</ArticleId><ArticleId IdType="pubmed">20015970</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Jeffries M, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, Merrill JT, McCune WJ, Sawalha AH (2013) Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in na&#xef;ve CD4+ T cells from lupus patients. J Autoimmun 43:78&#x2013;84</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.04.003</ArticleId><ArticleId IdType="pubmed">23623029</ArticleId><ArticleId IdType="pmc">3790645</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n JC, Hedrich CM, Tsokos GC (2013) Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol 9:476&#x2013;484</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2013.78</ArticleId><ArticleId IdType="pubmed">23732569</ArticleId></ArticleIdList></Reference><Reference><Citation>Durcan L, O&#x2019;Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393:2332&#x2013;2343</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30237-5</ArticleId><ArticleId IdType="pubmed">31180030</ArticleId></ArticleIdList></Reference><Reference><Citation>Godec J, Tan Y, Liberzon A, Tamayo P, Bhattacharya S, Butte AJ, Mesirov JP, Haining WN (2016) Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation. Immunity 44:194&#x2013;206</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.12.006</ArticleId><ArticleId IdType="pubmed">26795250</ArticleId><ArticleId IdType="pmc">5330663</ArticleId></ArticleIdList></Reference><Reference><Citation>Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR (2005) Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol 141:165&#x2013;173</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2005.02822.x</ArticleId><ArticleId IdType="pubmed">15958083</ArticleId><ArticleId IdType="pmc">1809425</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl FA, Beck-Garc&#xec;a E, Woessner NM, Flachsmann LJ, C&#xe1;rdenas RMV, Brandl SM, Taromi S, Fiala GJ, Morath A, Mishra P et al (2020) Noncanonical binding of Lck to CD3&#x3b5; promotes TCR signaling and CAR function. Nat Immunol 21:902&#x2013;913</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0732-3</ArticleId><ArticleId IdType="pubmed">32690949</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam SMT, Won J, Khan M, Mannie MD, Singh I (2021) Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases. Immunology 164:31&#x2013;42</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13335</ArticleId><ArticleId IdType="pubmed">33813735</ArticleId><ArticleId IdType="pmc">8358715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliche S, Breitling D, Togni M, Pusch R, Heuer K, Wang X, Freund C, Kasirer-Friede A, Menasche G, Koretzky GA et al (2006) The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1. Mol Cell Biol 26:7130&#x2013;7144</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00331-06</ArticleId><ArticleId IdType="pubmed">16980616</ArticleId><ArticleId IdType="pmc">1592884</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J (2000) Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol 149:181&#x2013;194</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.149.1.181</ArticleId><ArticleId IdType="pubmed">10747096</ArticleId><ArticleId IdType="pmc">2175102</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger F, Andrews SR (2011) Bismark: a flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics 27:1571&#x2013;1572</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr167</ArticleId><ArticleId IdType="pubmed">21493656</ArticleId><ArticleId IdType="pmc">3102221</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsd&#xf3;ttir H, Ghandi M, Mesirov JP, Tamayo P (2015) the molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1:417&#x2013;425</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId><ArticleId IdType="pmc">4707969</ArticleId></ArticleIdList></Reference><Reference><Citation>Matache C, Onu A, Stefanescu M, Tanaseanu S, Dragomir C, Dolganiuc A, Szegli G (2001) Dysregulation of p56lck kinase in patients with systemic lupus erythematosus. Autoimmunity 34:27&#x2013;38</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916930108994123</ArticleId><ArticleId IdType="pubmed">11681490</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacology 38:23&#x2013;38</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.112</ArticleId><ArticleId IdType="pubmed">22781841</ArticleId></ArticleIdList></Reference><Reference><Citation>Neo JYJ, Wee SYK, Bonne I, Tay SH, Raida M, Jovanovic V, Fairhurst AM, Lu J, Hanson BJ, MacAry PA (2019) Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus. Sci Rep 9:9998</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46329-y</ArticleId><ArticleId IdType="pubmed">31292492</ArticleId><ArticleId IdType="pmc">6620320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Lu MP, Wang JH, Xu M, Yang SR (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 16:19&#x2013;30</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Patwardhan MN, Wenger CD, Davis ES, Phanstiel DH (2019) Bedtoolsr: an r package for genomic data analysis and manipulation. J Open Source Softw. 4:44</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.01742</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498&#x2013;2504</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId><ArticleId IdType="pmc">403769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibbitt WL Jr, Mathews PM, Bankhurst AD (1983) Natural killer cell in systemic lupus erythematosus. defects in effector lytic activity and response to interferon and interferon inducers. J Clin Invest 71:1230&#x2013;1239</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI110872</ArticleId><ArticleId IdType="pubmed">6853711</ArticleId><ArticleId IdType="pmc">436983</ArticleId></ArticleIdList></Reference><Reference><Citation>Szyf M (2010) Epigenetic therapeutics in autoimmune disease. Clin Rev Allergy Immunol 39:62&#x2013;77</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-009-8172-8</ArticleId><ArticleId IdType="pubmed">19644776</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniyama Y, Weber DS, Rocic P, Hilenski L, Akers ML, Park J, Hemmings BA, Alexander RW, Griendling KK (2003) Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol 23:8019&#x2013;8029</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.22.8019-8029.2003</ArticleId><ArticleId IdType="pubmed">14585963</ArticleId><ArticleId IdType="pmc">262336</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Dasgupta A, Ward MM (2016) Risk of end-stage renal disease in patients with lupus nephritis, 1971&#x2013;2015: a systematic review and bayesian meta-analysis. Arthritis Rheumatol 68:1432&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39594</ArticleId><ArticleId IdType="pubmed">26815601</ArticleId><ArticleId IdType="pmc">5071782</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM (2017) Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 76:2009&#x2013;2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-211663</ArticleId><ArticleId IdType="pubmed">28794077</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC (2020) Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 21:605&#x2013;614</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0677-6</ArticleId><ArticleId IdType="pubmed">32367037</ArticleId><ArticleId IdType="pmc">8135909</ArticleId></ArticleIdList></Reference><Reference><Citation>von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B (2003) STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 31:258&#x2013;261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg034</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeding E, Sawalha AH (2018) Deoxyribonucleic acid methylation in systemic lupus erythematosus: implications for future clinical practice. Front Immunol 9:875</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00875</ArticleId><ArticleId IdType="pubmed">29740453</ArticleId><ArticleId IdType="pmc">5928134</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Chang C, Lu Q (2020) The epigenetics of lupus erythematosus. Adv Exp Med Biol 1253:185&#x2013;207</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-3449-2_7</ArticleId><ArticleId IdType="pubmed">32445096</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an r package for comparing biological themes among gene clusters. OMICS 16:284&#x2013;287</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId><ArticleId IdType="pmc">3339379</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Mei D, Zhang L, Wei W (2021) Src family protein kinase controls the fate of b cells in autoimmune diseases. Inflammation 44:423&#x2013;433</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-020-01355-1</ArticleId><ArticleId IdType="pubmed">33037966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, Liu Y, Jiang J, Luo S, Tan Y et al (2016) IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis 75:1998&#x2013;2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-208410</ArticleId><ArticleId IdType="pubmed">26787370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>